|
Volumn 42, Issue 10, 2010, Pages 4582-4584
|
Treating hepatocellular carcinoma with sorafenib in liver transplant patients: An initial experience
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA FETOPROTEIN;
ANTIDIARRHEAL AGENT;
SORAFENIB;
ABSENCE OF SIDE EFFECTS;
ADULT;
ASCITES;
BRAIN METASTASIS;
CHEMOEMBOLIZATION;
CLINICAL ARTICLE;
CONFERENCE PAPER;
DIARRHEA;
DRUG DOSE INCREASE;
DRUG DOSE REDUCTION;
DRUG ERUPTION;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
DYSPNEA;
FEMALE;
FOOD POISONING;
HEPATITIS B;
HUMAN;
LEG CRAMP;
LEG EDEMA;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
LIVER RESECTION;
LIVER TRANSPLANTATION;
MALE;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
RADIOFREQUENCY ABLATION;
RECURRENT CANCER;
SPINE METASTASIS;
SURGICAL PATIENT;
TREATMENT OUTCOME;
TUMOR DIFFERENTIATION;
ANTINEOPLASTIC AGENTS;
BENZENESULFONATES;
CARCINOMA, HEPATOCELLULAR;
COMBINED MODALITY THERAPY;
FEMALE;
HUMANS;
LIVER NEOPLASMS;
LIVER TRANSPLANTATION;
MALE;
MIDDLE AGED;
PYRIDINES;
|
EID: 78650460656
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2010.09.147 Document Type: Conference Paper |
Times cited : (21)
|
References (12)
|